Management of type 2 diabetes: Long-awaited evidence of benefits after blood sugar control

Prescrire International

Volumn 8, Issue 43, 1999, Pages 147-152

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; INSULIN; METFORMIN;

ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; HUMAN; HYPOGLYCEMIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED KINGDOM;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GLYBURIDE; GREAT BRITAIN; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033206795     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Goldner MG et al. for the University Group Diabetes Program "Effects of hypoglycemic agents on vascular complications in patients with adult-onset Diabetes-III. Clinical implications of UGDP results" JAMA 1971; 218: 1400-1410. Knatterud GL et al. for the University Group Diabetes Program "Effects of hypoglycemic agents on vascular complications in patients with adult-onset Diabetes-IV. A preliminary report on phenformin results" JAMA 1971; 217: 773-784. Summarised in: "What use are oral antidiabetic drugs?" Prescr Intern 1996; 5 (26): 186-190.
2. Goldner MG et al. for the University Group Diabetes Program "Effects of hypoglycemic agents on vascular complications in patients with adult-onset Diabetes-III. Clinical implications of UGDP results" JAMA 1971; 218: 1400-1410. Knatterud GL et al. for the University Group Diabetes Program "Effects of hypoglycemic agents on vascular complications in patients with adult-onset Diabetes-IV. A preliminary report on phenformin results" JAMA 1971; 217: 773-784. Summarised in: "What use are oral antidiabetic drugs?" Prescr Intern 1996; 5 (26): 186-190.
3. Goldner MG et al. for the University Group Diabetes Program "Effects of hypoglycemic agents on vascular complications in patients with adult-onset Diabetes-III. Clinical implications of UGDP results" JAMA 1971; 218: 1400-1410. Knatterud GL et al. for the University Group Diabetes Program "Effects of hypoglycemic agents on vascular complications in patients with adult-onset Diabetes-IV. A preliminary report on phenformin results" JAMA 1971; 217: 773-784. Summarised in: "What use are oral antidiabetic drugs?" Prescr Intern 1996; 5 (26): 186-190.
4. Prout TE et al. for the University Group Diabetes Program "The UGDP controversy. Clinical trial versus clinical impressions" Diabetes 1972; 21: 1035-1040.
5. Stout RW "Diabetes and atherosclerosis - The role of insulin" Diabetologia 1979; 16: 141-150.
6. UK Prospective Diabetes Study (UKPDS) Group "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)" Lancet 1998; 352: 837-853.
7. UK Prospective Diabetes Study (UKPDS) Group "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)" Lancet 1998; 352: 854-865.
8. Turner R et al. for the United Kingdom Prospective Diabetes Study Group "United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus" Ann Intern Med 1996; 124 (1 (part 2)): 136-145.
9. Nathan DM "Some answers, more controversy, from UKPDS" Lancet 1998; 352: 832-833.
10. The Diabetes Control and Complications Trial Research Group "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus" N Engl J Med 1993; 329: 977-986. Summarised in: "Prevention of complications of insulin-dependent diabetes mellitus by intensive insulin therapy" Prescr Intern 1994; 3 (13): 158.
11. The Diabetes Control and Complications Trial Research Group "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus" N Engl J Med 1993; 329: 977-986. Summarised in: "Prevention of complications of insulin-dependent diabetes mellitus by intensive insulin therapy" Prescr Intern 1994; 3 (13): 158.
12. Reichard P et al. "Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up" Diabetologia 1996; 39: 1483-1488.
13. Brady PA and Terzic A "The sulfonylurea controversy: more questions from the heart" J Am Coll Cardiol 1998; 31: 950-956.
14. UK Prospective Diabetes Study Group "Tight blood-pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)" BMJ 1998; 317: 703-713.
15. UK Prospective Diabetes Study Group "Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)" BMJ 1998; 317: 713-720.
16. "Antihypertensive drugs; diuretics and beta-blockers are the best assessed" Prescr Intern 1999; 8 (41): 90-95.
17. Metropolitan Life Insurance Company "New weight standards for men and women" Statist Bull 1959; 40: 1-4.
18. Ohkubo Y et al. "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependant diabetes mellitus: a randomized prospective 6-year study" Diabetes Res Clin Pract 1995; 28: 103-117.